1. Home
  2. CERO vs FTFT Comparison

CERO vs FTFT Comparison

Compare CERO & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • FTFT
  • Stock Information
  • Founded
  • CERO 2017
  • FTFT N/A
  • Country
  • CERO United States
  • FTFT United States
  • Employees
  • CERO N/A
  • FTFT N/A
  • Industry
  • CERO
  • FTFT Business Services
  • Sector
  • CERO
  • FTFT Consumer Discretionary
  • Exchange
  • CERO Nasdaq
  • FTFT Nasdaq
  • Market Cap
  • CERO 8.5M
  • FTFT 8.7M
  • IPO Year
  • CERO N/A
  • FTFT N/A
  • Fundamental
  • Price
  • CERO $0.06
  • FTFT $0.30
  • Analyst Decision
  • CERO
  • FTFT
  • Analyst Count
  • CERO 0
  • FTFT 0
  • Target Price
  • CERO N/A
  • FTFT N/A
  • AVG Volume (30 Days)
  • CERO 33.3M
  • FTFT 406.2K
  • Earning Date
  • CERO 11-19-2024
  • FTFT 11-19-2024
  • Dividend Yield
  • CERO N/A
  • FTFT N/A
  • EPS Growth
  • CERO N/A
  • FTFT N/A
  • EPS
  • CERO N/A
  • FTFT N/A
  • Revenue
  • CERO N/A
  • FTFT $18,543,659.00
  • Revenue This Year
  • CERO N/A
  • FTFT N/A
  • Revenue Next Year
  • CERO N/A
  • FTFT N/A
  • P/E Ratio
  • CERO N/A
  • FTFT N/A
  • Revenue Growth
  • CERO N/A
  • FTFT N/A
  • 52 Week Low
  • CERO $0.05
  • FTFT $0.26
  • 52 Week High
  • CERO $12.80
  • FTFT $2.60
  • Technical
  • Relative Strength Index (RSI)
  • CERO 39.14
  • FTFT 40.23
  • Support Level
  • CERO $0.05
  • FTFT $0.26
  • Resistance Level
  • CERO $0.21
  • FTFT $0.52
  • Average True Range (ATR)
  • CERO 0.02
  • FTFT 0.05
  • MACD
  • CERO -0.01
  • FTFT -0.01
  • Stochastic Oscillator
  • CERO 14.60
  • FTFT 21.50

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.

Share on Social Networks: